FDA Tobacco Review Delays Threaten Public Health, GAO Report Reveals

A September 2026 report from the Government Accountability Office (GAO) has revealed administrative bottlenecks within the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). With over 131,000 product applications stalled for an average of nearly 3.5 years, these regulatory delays pose measurable risks to public health and adult smoking cessation.

Cigarette smoking and secondhand smoke claim more than 480,000 lives each year in the United States. While quitting smoking reduces the risk of premature death, administrative stalls prevent smokers from accessing authorized, lower-risk alternatives.

Unpacking the Multi-Year Application Backlog

The GAO report details systemic gaps in the CTP’s capacity to track and complete scientific reviews. As of December 31, 2025, exactly 131,915 tobacco-product applications submitted between 2018 and 2025 remained without completed determinations.

These pending applications span multiple review pathways and averaged 1,266 days in limbo. The Department of Health and Human Services has agreed with GAO recommendations to collect better tracking data to monitor review timelines without compromising scientific scrutiny.

Evaluating Cessation Rates and Reduced-Risk Options

Data from the Centers for Disease Control and Prevention (CDC) shows that approximately two-thirds of adult smokers want to quit, and more than half attempt to do so annually. However, fewer than one in 10 succeed. While approved medications and counseling exist, noncombustible products offer another viable off-ramp.

The CTP recognizes that noncombustible options, including e-cigarettes and nicotine pouches, carry lower health risks than traditional cigarettes because they do not burn tobacco. A 2025 Cochrane review confirmed high-certainty evidence supporting this transition:

Nicotine E-Cigarettes: Lead to successful cessation in 8 to 11 out of every 100 people for at least six months.
Nicotine Replacement Therapy: Results in successful cessation for roughly 6 out of every 100 people using patches or gum.

Quitting combustible cigarettes produces rapid health returns. Adults who stop smoking between ages 45 and 54 gain an estimated six years of life, while cardiovascular risks drop within one to two years.

Market Restrictions and the Risk of Cigarette Substitution

Restricting access to alternatives can produce unintended public health consequences. A 2024 multi-state study evaluating adults aged 18 to 29 found that state-level flavor bans correlated with a 2.2-percentage-point increase in daily cigarette smoking relative to control trends. Parallel retail analyses also linked reduced e-cigarette sales to increases in combustible cigarette sales.

Product Category / Factor	Cessation & Health Impact	Regulatory & Market Status
Combustible Cigarettes	Responsible for 480,000+ annual US deaths	Fully accessible nationwide
Nicotine E-Cigarettes	8–11 quitters per 100 users (Cochrane Review)	131,000+ applications backlogged at FDA
Nicotine Replacement Therapy	6 quitters per 100 users (Patches/Gums)	Standard FDA-approved method

These findings indicate that when alternative products are restricted or delayed, nicotine users frequently substitute combustible cigarettes rather than quitting nicotine altogether.

Balancing Speed and Scientific Oversight

The CTP is legally tasked with evaluating population-wide risks, including youth uptake and non-smoker protections. However, an effective regulatory framework must balance scrutiny with administrative efficiency.

Avoidable review delays keep adult smokers tied to combustible products while safer alternatives await regulatory decisions. Faster, science-based determinations are essential to safeguard youth while allowing adults to transition away from combustible tobacco.

Source: The Public Health Cost of FDA’s Tobacco Review Delays

Author
Recent Posts

Matthew Ma

Marketing at Ecigator

With over a decade of experience in the e-cigarette industry, Matthew Ma is a seasoned expert in both the manufacturing and usage aspects of vaping products. His extensive background has provided him with a deep understanding of the intricacies and evolving dynamics of e-cigarettes.